Abstract
Purpose. The stereoselective distribution of three basic drugs, disopyramide (DP), flecainide (FLC) and verapamil (VP), was studied to clarify the relationships between the tissue-to-unbound plasma concentration ratio (Kpf) and drug lipophilicity and binding to phosphatidylserine (PhS), which are possible factors determining the tissue distribution of these drug enantiomers.
Methods. The drug enantiomer or racemate was administered to rats by intravenous constant infusion. Their concentrations in plasma and tissues were determined using enantioselective high-performance liquid chromatography. Plasma protein binding, and buffer-octanol and buffer-hexane containing PhS partition coefficients were also determined.
Results. The stereoselectivity of the tissue-to-plasma concentration ratio (Kp) was partly associated with that of serum protein binding. However, the Kpf value of R( + )-VP in the lung was significantly higher than that of S(−)-VP. A linear correlation was observed between the Kpf values of these drug enantiomers in brain, heart, lung and muscle, and their buffer-hexane containing PhS partition coefficients. The in vitrodata for the binding of these drugs to PhS suggest that stereoselective binding of VP to PhS may correspond to its stereoselective tissue binding.
Conclusions. Our findings provide some evidence for a role of tissue PhS in the tissue distribution of basic drugs with respect to stereoselectivity of drug enantiomers distribution.
Similar content being viewed by others
REFERENCES
K. Yokogawa, E. Nakashima, J. Ishizaki, H. Maeda, T. Nagano, and F. Ichimura. Relationships in the structure-tissue distribution of basic drugs in the rabbit. Pharm. Res. 7:691-696 (1990).
T. Terasaki, T. Iga, Y. Sugiyama, and M. Hanano. Pharmacokinetic study on the mechanism of tissue distribution of doxorubicin: Interorgan and interspecies variation of tissue-to-plasma partition coefficients in rats, rabbits, and guinea pigs. J. Pharm. Sci. 73:1359-1363 (1984).
K. Wierzba, Y. Sugiyama, K. Okudaira, T. Iga, and M. Hanano. Tubulin as a major determinant of tissue distribution of vincristine. J. Pharm. Sci. 76:872-875 (1987).
A. Nishiura, T. Murakami, Y. Higashi, and N. Yata. Role of phosphatidylserine in the cellular and subcellular lung distribution of quinidine in rats. Pharm. Res. 5:209-213 (1988).
N. Yata, T. Toyoda, T. Murakami, A. Nishiura, and Y. Higashi. Phosphatidylserine as a determinant for the tissue distribution of weakly basic drugs in rats. Pharm. Res. 7: 1019-1025 (1990).
K. Williams and E. Lee. Importance of drug enantiomers in clinical pharmacology. Drugs 32:333-354 (1985).
M. Eichelbaum. Pharmacokinetics and pharmacodynamic consequences of stereoselective drug metabolism in man. Biochem. Pharmacol. 37:93-96 (1988).
H. Takahashi, H. Ogata, S. Kanno, and H. Takeuchi. Plasma protein binding of propranolol enantiomers as a major determinant of their stereoselective tissue distribution in rats. J. Pharmacol. Exp. Ther. 252:272-278 (1990).
L. Igwemezie, G. N. Beatch, M. J. A. Walker, and K. M. McErlane. Tissue distribution of mexiletine enantiomers in rats. Xenobiotica 21:1153-1158 (1991).
K. Hanada, S. Akimoto, K. Mitsui, M. Hashiguchi, and H. Ogata. Quantitative determination of disopyramide, verapamil and flecainide enantiomers in rat plasma and tissues by high-performance liquid chromatography. J. Chromatogr. B 710:129-135 (1998).
F. Morady, M. M. Scheinman, and J. Desai. Disopyramide. Ann. Intern. Med. 96:337 (1982).
B. Holmes and R. C. Heel. A preliminary review of its pharmacodynamic properties and therapeutic efficacy. Drugs 29:1-3 (1985).
B. N. Singh, G. Ellrodt, and C. T. Peter. Verapamil. A review of its pharmacological properties and therapeutic use. Drugs 15:169-171 (1978).
H. S. G. Chen and J. F. Gross. Estimation of tissue-to-plasma partition coefficients used in physiological pharmacokinetic models. J. Pharmacokin. Biopharm. 7:117-125 (1979).
H. Takahashi, A. Tamura, H. Ogata, and K. Masuhara. Simultaneous determination of disopyramide and its mono-N-dealkylated metabolite enantiomers in human plasma and urine by enantioselective high-performance liquid chromatography. J. Chromatogr. 529:347-358 (1990).
O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:265-275 (1951).
J. J. Lima, G. Jungbluth, T. Devine, and L. Robertson. Stereoselective binding of disopyramide to human plasma protein. Life Sci. 35:835 (1984).
A. Tsuji, T. Terasaki, Y. Takabatake, Y. Tenda, I. Tamai, T. Yamashita, S. Moritani, T. Tsuruo, and J. Yamashita. P-glycoprotein as the drug efflux pump in primary cultured bovine brain capillary endothelial cells. Life Sci. 51:1427-1437 (1992).
H. Harashima, Y. Sugiyama, Y. Sawada, T. Iga, and M. Hanano. Analysis of nonlinear tissue distribution of quinidine in rats by physiologically based pharmacokinetics. J. Pharmacokin. Biopharm. 13:425-440 (1985).
K. Iwamoto, J. Watanabe, K. Araki, N. Deguchi, and H. Sugiyama. Effect of age on the hepatic clearance of propranolol in rats. J. Pharm. Pharmacol. 37:466-470 (1985).
M. Chiba, S. Fujita, and T. Suzuki. Paralle pathway interactions in imipramine metabolism in rats. J. Pharm. Sci. 77:944-947 (1988).
A. S. Gross and A. A. Somogyi. Interaction of stereoisomers of basic drugs with the uptake of tetraethylammonium by rat renal brush-border membrane vesicles. J. Pharmacol. Exp. Ther. 268:1073-1080 (1993).
K. M. Giacomini, W. L. Nelson, R. A. Pershe, L. Valdivieso, K. Turner-Tamiyasu, and T. F. Blaschke. In vivointeraction of the enantiomers of disopyramide in human subjects. J. Pharmacokin. Biopharm. 14:335-356 (1986).
M. Eichelbaum, G. Mikus, and B. Vogelgesang. Pharmacokinetics of (+)-, (−)-and (±)-verapamil after intravenous administration. Br. J. Clin. Pharmacol. 17:453-458 (1984).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hanada, K., Akimoto, S., Mitsui, K. et al. Enantioselective Tissue Distribution of the Basic Drugs Disopyramide, Flecainide and Verapamil in Rats: Role of Plasma Protein and Tissue Phosphatidylserine Binding. Pharm Res 15, 1250–1256 (1998). https://doi.org/10.1023/A:1011948126170
Issue Date:
DOI: https://doi.org/10.1023/A:1011948126170